Screening for Depression in the General Population with the Center for Epidemiologic Studies Depression (CES-D): A Systematic Review with Meta-Analysis.

Vilagut G, Forero CG, Barbaglia G, Alonso J. · 2016

Read Screening for Depression in the General Population with the Center for Epidemiologic Studies Depression (CES-D): A Systematic Review with Meta-Analysis. by Vilagut G, Forero CG, Barbaglia G, Alonso J. (2016) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc4868329.txt.

Introduction

Gemma Vilagut and co-authors pooled studies in 2016 on how well a common mood questionnaire, the CES-D, screens for depression in the general public. Clinics need a cheap first pass to catch hidden depression. The review gathered validation studies from community and primary care samples where scores were checked against full diagnostic interviews, the gold standard.

Pooled results give hit and miss rates at several score cutoffs, plus an overall accuracy curve. Study quality and mixed results across settings get close review. At common cutoffs the scale catches most true cases while flagging some healthy people. The numbers help clinics pick a cutoff that fits their time and follow-up capacity.

Catalog record

CREATORVilagut G, Forero CG, Barbaglia G, Alonso J.
YEAR2016
COLLECTIONPAPERS
FORMATTXT
FILE SIZE53 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC4868329

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Screening for Depression in the General Population with the Center for Epidemiologic Studies Depression (CES-D): A Systematic Review with Meta-Analysis By Gemma Vilagut, Carlos G. Forero, Gabriela Barbaglia, Jordi Alonso, Christina van der Feltz-Cornelis Published in: PLoS ONE DOI: 10.1371/journal.pone.0155431 ABSTRACT Objective We aimed to collect and meta-analyse the existing evidence regarding the performance of the Center for Epidemiologic Studies Depression (CES-D) for detecting depression in general population and primary care settings. Method Systematic literature search in PubMed and PsychINFO. Eligible studies were: a) validation studies of screening questionnaires with information on the accuracy of the CES-D; b) samples from general populations or primary care settings; c) standardized diagnostic interviews following standard classification systems used as gold standard; and d) English or Spanish language of publication. Pooled sensitivity, specificity, likelihood ratios and diagnostic odds ratio were estimated for several cut-off points using bivariate mixed effects models for each threshold. The summary receiver operating characteristic curve was estimated with Rutter and Gatsonis mixed effects models; area under the curve was calculated. Quality of the studies was assessed with the QUADAS tool. Causes of heterogeneity were evaluated with the Rutter and Gatsonis mixed effects model including each covariate at a time. Results 28 studies (10,617 participants) met eligibility criteria. The median prevalence of Major Depression was 8.8% (IQ range from 3.8% to 12.6%). The overall area under the curve was 0.87. At the cut-off 16, sensitivity was 0.87 (95% CI: 0.82–0.92), specificity 0.70 (95% CI: 0.65–0.75), and DOR 16.2 (95% CI: 10.49–25.10). Better trade-offs between sensitivity and specificity were observed (Sensitivity = 0.83, Specificity = 0.78, diagnostic odds ratio = 16.64) for cut-off 20. None of the variables assessed as possible sources of heterogeneity was found to be statistically significant. Conclusion The CES-D has acceptable screening accuracy in the general population or primary care settings, but it should not be used as an isolated diagnostic measure of depression. Depending on the test objectives, the cut-off 20 may be more adequate than the value of 16, which is typically recommended. INTRODUCTION Major Depression ranks amongst the most burdensome health conditions, both at individual and population levels [1–3]. It is the most frequent mood disorder, with a lifetime prevalence that has been reported to range from 7% to 21% [4]. It is also associated with a substantial functional impairment, diminished quality of life, increased burden, both for patients and caregivers, as well as with a higher risk of mortality [4–6]. That notwithstanding, it is estimated that about 50% of depressed patients are incorrectly identified by general practitioners in routine unassisted diagnosis of depression [7], and that only a limited proportion of cases receive adequate treatment [8;9]. Given these figures, systematic screening has been advocated as a means for improving detection, treatment and outcomes of depression, and also to facilitate follow-up of patients’ progress [10;11]. Depression screening would also be important in primary care and general population settings for monitoring disease prevalence [12], as well as for targeting interventions at either individual or group level. Therefore, there is an increasing need for evidence about the accuracy (the ability to discriminate between people with the disorder and those without it) of different assessment methods. A number of excellent exhaustive diagnostic instruments exist for depression diagnosis (i.e. Diagnostic Interview Schedule (DIS); Composite International Diagnostic Interview (CIDI); Schedules for Clinical Assessment in Neuropsychiatry (SCAN); Mini-International Neuropsychiatric Interview (MINI); Structured Clinical Interview for DSM Disorder (SCID) [12]), but they are generally unfeasible in population-based surveys. Using such instruments is also unattainable in clinical applications with stringent time-demands, and thus outside specialized mental health care services. In contrast, brief, self-reported scales are economical, can be readily applied requiring neither extensive training nor time, and have been found to be sensitive to changes over time. Several short scales have been developed to ascertain the presence of depression in general population surveys and primary care samples [13]. Arguably, the Center for Epidemiologic Studies Depression Scale (CES-D) [14] is one of the most widespread brief scales for assessing depression. Originally devised for screening and research in general population epidemiological studies and primary care, the CES-D has also been extensively used in other settings, as a measure of depressive symptomatology among individuals with specific chronic conditions [15;16], and even as a stand-alone diagnostic measure of depression [17–19]. A simple search in bibliographic databases retrieves thousands of population-based and clinical studies using the CES-D in the last ten years. A number of these studies have evaluated the diagnostic accuracy of the CES-D to detect major depression at the general population and primary care levels. In spite of its prominence, no work has been done to date to integrate the results on its performance through meta-analysis. A meta-analytic approach would be important for the CES-D, since it would provide precise and generalizable evidence about the performance of the CES-D and the interpretation of its results, and to establish whether and how associated findings vary by particular subgroups [20;21]. Aims of the study The aim of our study was to collect and analyse all the existing evidence regarding the performance of the CES-D scale to detect major depression in general populations and primary care. This was done through: a) a systematic review to identify the studies evaluating the accuracy (or criterion-related validity) of the CES-D for major depressive disorder in the general population or primary care; and b) a meta-analysis of the available literature. MATERIAL AND METHODS The Center for Epidemiologic Studies Depression (CES-D) Scale The CES-D scale is a short self-report scale designed to measure the current level of depressive symptomatology in the general population [14]. It contains 20 items about symptoms that occurred in the week prior to the interview with response options from 0 to 3 that refer to frequency of the symptoms. The score ranges between 0 (best possible) to 60 (worst) and the cut-off point that has been typically recommended for depression caseness is 16 [22]. Individuals with a score of 16 or more must have had either at least 6 of the 20 symptoms in the CES-D with persistence for most of the previous week, or a majority of the symptoms on the scale for shorter periods of time. CES-D literacy level has been defined as easy, and it takes between 2 and 5 minutes to complete. Search strategy We searched for articles in two databases, PubMed and PsychINFO (EBSCOHost), for English and Spanish language journal articles published from January 1st, 1977 through June 15th, 2015 (date last searched: June 25th, 2015). Search terms included three components that had to be fulfilled. The first component referred to the assessment of mental disorders and included the MeSH terms “mental disorders”, or “anxiety disorders”, or “anxiety”, or “depressive disorder”, combined with the terms “depressive* or depression* or anxiety* or mental disorder*” in title or abstract. The second component dealt with screening instruments and included the MeSH terms “Mass screening”, or “screen*”, and the names of common screening and diagnostic instruments, including “CES-D”, or “CESD”, or “Center for Epidemiologic Studies Depression Scale”, in title or abstract. Finally, the third component had to do with the assessment of the diagnostic accuracy of the instruments including terms related with validation studies, like ROC analysis or sensitivity

Read the complete text